Matinas' lead drug is MAT 9001, an omega drug that
Post# of 154127
(Total Views: 408)
Posted On: 12/14/2019 12:18:31 PM
Matinas' lead drug is MAT 9001, an omega drug that handily beat FDA approved Vascepa in a head to head trial.
Matinas has partnerships with three big pharmaceutical companies, recently received $25 million in non-dilutive financing from a major health care fund, and one of its other drugs is in clinical trials being run and paid for by the NIH, that has publicly stated it has great hope for this drug.
Matinas needs no funding for at least a year, at which time it will have many further results in hand.
And its stock has increased 400% in the past year.
If I had invested my CYDY money in Matinas, I would be one happy camper.
Do some more due diligence on Matinas, including listening to some of Jerry Jabbour's presentations, that are on Matinas' website, and you might choose to invest in that company as well.
Oh, by the way, MTNB went up about 20% on Friday.
Best of luck to you.
LM
Matinas has partnerships with three big pharmaceutical companies, recently received $25 million in non-dilutive financing from a major health care fund, and one of its other drugs is in clinical trials being run and paid for by the NIH, that has publicly stated it has great hope for this drug.
Matinas needs no funding for at least a year, at which time it will have many further results in hand.
And its stock has increased 400% in the past year.
If I had invested my CYDY money in Matinas, I would be one happy camper.
Do some more due diligence on Matinas, including listening to some of Jerry Jabbour's presentations, that are on Matinas' website, and you might choose to invest in that company as well.
Oh, by the way, MTNB went up about 20% on Friday.
Best of luck to you.
LM
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
The Lawman
style="color:red">The Lawman"color:red">The Lawman:red">The LawmanThe Lawmanspan>Lawmanawmanimg]